| Progress in our understanding of the pathogenesis of ankylosing spondylitis D Simone, MH Al Mossawi, P Bowness Rheumatology 57 (suppl_6), vi4-vi9, 2018 | 145 | 2018 |
| Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis MH Al-Mossawi, L Chen, H Fang, A Ridley, J De Wit, N Yager, ... Nature communications 8 (1), 1510, 2017 | 134 | 2017 |
| Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis F Penkava, MDC Velasco-Herrera, MD Young, N Yager, LN Nwosu, ... Nature communications 11 (1), 4767, 2020 | 132 | 2020 |
| Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey R Ramonda, A Marchesoni, A Carletto, G Bianchi, M Cutolo, G Ferraccioli, ... Arthritis research & therapy 18, 1-7, 2016 | 77 | 2016 |
| miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis L Chen, MH Al-Mossawi, A Ridley, T Sekine, A Hammitzsch, J De Wit, ... Annals of the rheumatic diseases 76 (3), 620-625, 2017 | 72 | 2017 |
| Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates D Simone, F Penkava, A Ridley, S Sansom, MH Al-Mossawi, P Bowness Communications biology 4 (1), 1395, 2021 | 38 | 2021 |
| Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases A Hammitzsch, L Chen, J de Wit, MH Al-Mossawi, A Ridley, T Sekine, ... Scientific Reports 8 (1), 15645, 2018 | 34 | 2018 |
| Novel immune cell phenotypes in spondyloarthritis pathogenesis D Mauro, D Simone, L Bucci, F Ciccia Seminars in Immunopathology 43, 265-277, 2021 | 27 | 2021 |
| Real-life efficacy of guselkumab in patients with early psoriatic arthritis I Pantano, D Mauro, F Romano, A Gambardella, M Valenti, D Simone, ... Rheumatology 61 (3), 1217-1221, 2022 | 18 | 2022 |
| Disease-modifying antirheumatic drugs (DMARD) and combination therapy of conventional DMARD in patients with spondyloarthritis and psoriatic arthritis with axial involvement D Simone, M Nowik, E Gremese, GF Ferraccioli The Journal of Rheumatology Supplement 93, 65-69, 2015 | 10 | 2015 |
| Genetic and environmental determinants of T helper 17 pathogenicity in spondyloarthropathies D Simone, A Stingo, F Ciccia Frontiers in Genetics 12, 703242, 2021 | 4 | 2021 |
| Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years F Iannone, F Salaffi, A Marchesoni, R Gorla, F Atzeni, M Govoni, ... Clinical and Experimental Rheumatology 33 (4), 524-530, 2015 | 3 | 2015 |
| Genetically encoded Runx3 and CD4+ intestinal epithelial lymphocyte deficiencies link SKG mouse and human predisposition to spondyloarthropathy ZA Bhuyan, MA Rahman, MR Maradana, AM Mehdi, AS Bergot, D Simone, ... Clinical Immunology 247, 109220, 2023 | 2 | 2023 |
| A Mitogen-Associated Protein Kinase (MAPK) Associated Kinase 2 Inhibitor Decreases in Vitro Th17 and Monocyte Inflammatory Responses in Spondyloarthritis D Simone, H Shi, N Ansar, A Davies, K Doig, P Bowness ARTHRITIS & RHEUMATOLOGY 69, 2017 | | 2017 |
